Amgen Inc

AMGN · NASDAQ · Healthcare / Drug Manufacturers - General

465.67USD-1.39 (-0.30%)

Price History

Full chart

Market Stats

Previous Close467.06

Open467.53

Day Range462.22 – 468.00

52-Week Range306.13 – 483.99

Volume2.12M

Market Cap251.65B

P/E (TTM)26.97

Forward P/E18.83

EPS17.25

Dividend Yield2.17%

Beta0.42

50-Day Avg422.43

200-Day Avg378.01

About

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

Company Details

SectorHealthcare
IndustryDrug Manufacturers - General
CEOMr. Robert A. Bradway
Employees31.50K
HeadquartersOne Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799, USA
Websitehttps://www.amgen.com

Leadership

Mr. Robert A. BradwayChairman & CEO · b. 1963
Mr. Murdo GordonExecutive Vice President of Global Markets and Policy · b. 1967

Financials

Income Statement

Currency: USD	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	29.80M	44.30M	70.20M	190.40M	190.40M	679.80M	1.08B	1.35B	1.62B	1.90B	2.20B	2.35B	2.64B	3.20B	3.45B	4.02B	5.52B	8.36B	10.55B	12.43B	14.27B	14.77B	15.00B	14.64B	15.05B	15.58B	17.27B	18.68B	20.06B	21.66B	22.99B	22.85B	23.75B	23.36B	25.42B	25.98B	26.32B	28.19B	33.42B	36.74B
Growth (%)	-	+48.66%	+58.47%	+171.23%	0.00%	+257.04%	+58.91%	+25.42%	+19.57%	+17.52%	+15.46%	+6.71%	+12.64%	+21.27%	+7.62%	+16.45%	+37.54%	+51.29%	+26.26%	+17.82%	+14.79%	+3.53%	+1.57%	-2.41%	+2.81%	+3.51%	+10.80%	+8.17%	+7.43%	+7.97%	+6.14%	-0.62%	+3.93%	-1.62%	+8.83%	+2.18%	+1.32%	+7.09%	+18.57%	+9.92%
Cost of Revenue	21.80M	35.50M	44.00M	14.70M	14.70M	91.20M	151.20M	169.30M	163.60M	188.70M	182.90M	183.70M	201.40M	225.30M	196.60M	443.00M	735.70M	1.34B	1.73B	2.08B	2.10B	2.55B	2.30B	2.09B	2.22B	2.43B	2.92B	3.35B	4.42B	4.23B	4.16B	4.07B	4.10B	4.36B	6.16B	6.45B	6.41B	8.45B	12.86B	10.73B
Gross Profit	8.00M	8.80M	26.20M	175.70M	175.70M	588.60M	929.10M	1.19B	1.46B	1.72B	2.02B	2.16B	2.44B	2.98B	3.25B	3.57B	4.79B	7.02B	8.82B	10.35B	12.17B	12.22B	12.71B	12.55B	12.83B	13.15B	14.35B	15.33B	15.64B	17.43B	18.83B	18.78B	19.65B	19.01B	19.27B	19.52B	19.92B	19.74B	20.57B	26.01B
Gross Margin	26.85%	19.86%	37.32%	92.28%	92.28%	86.58%	86.00%	87.50%	89.90%	90.09%	91.68%	92.17%	92.38%	92.97%	94.30%	88.97%	86.68%	83.96%	83.59%	83.25%	85.32%	82.75%	84.70%	85.72%	85.25%	84.42%	83.10%	82.08%	77.96%	80.49%	81.90%	82.19%	82.73%	81.35%	75.77%	75.16%	75.66%	70.02%	61.53%	70.80%
Operating Expense	9.40M	14.40M	31.00M	146.60M	124.60M	465.20M	431.00M	634.40M	757.90M	954.30M	1.10B	1.23B	1.32B	1.65B	1.88B	2.04B	5.57B	3.92B	5.47B	5.50B	8.33B	8.24B	7.49B	7.04B	7.29B	8.84B	8.77B	9.46B	9.45B	8.96B	9.04B	8.81B	9.38B	9.33B	10.13B	11.89B	10.35B	11.84B	13.31B	15.34B
Operating Income	-1.40M	-5.60M	-4.80M	29.10M	51.10M	123.40M	498.10M	551.20M	698.50M	760.80M	916.00M	930.30M	1.12B	1.32B	1.37B	1.53B	-785.00M	3.09B	3.35B	4.85B	3.84B	3.98B	5.21B	5.51B	5.54B	4.31B	5.58B	5.87B	6.19B	8.47B	9.79B	9.97B	10.26B	9.67B	9.14B	7.64B	9.57B	7.90B	7.26B	10.68B
Operating Margin	-4.70%	-12.64%	-6.84%	15.28%	26.84%	18.15%	46.11%	40.68%	43.12%	39.96%	41.67%	39.66%	42.33%	41.35%	39.67%	38.13%	-14.21%	36.99%	31.73%	39.00%	26.91%	26.94%	34.75%	37.60%	36.84%	27.67%	32.30%	31.41%	30.86%	39.10%	42.60%	43.65%	43.22%	41.41%	35.95%	29.40%	36.34%	28.01%	21.71%	29.06%
EBITDA	1.20M	-1.50M	3.20M	68.80M	68.80M	144.90M	531.70M	601.90M	773.00M	845.00M	1.02B	1.05B	1.26B	1.50B	1.58B	1.80B	2.65B	3.78B	4.64B	5.69B	6.03B	5.98B	6.64B	6.83B	6.94B	5.82B	7.15B	7.57B	8.75B	11.18B	12.53B	12.86B	12.88B	12.63B	13.00B	11.30B	12.17B	7.90B	13.36B	16.90B
EBITDA Margin	4.03%	-3.39%	4.56%	36.13%	36.13%	21.32%	49.22%	44.42%	47.72%	44.38%	46.24%	44.65%	47.77%	46.87%	45.82%	44.75%	48.05%	45.21%	43.94%	45.77%	42.29%	40.49%	44.25%	46.65%	46.09%	37.35%	41.41%	40.55%	43.60%	51.62%	54.49%	56.27%	54.25%	54.07%	51.12%	43.48%	46.23%	28.01%	39.96%	45.99%
Net Income	800.00K	1.70M	-8.20M	19.10M	19.10M	97.90M	357.60M	383.30M	319.70M	537.70M	679.80M	644.30M	863.20M	1.10B	1.14B	1.12B	-1.39B	2.26B	2.36B	3.67B	2.95B	3.17B	4.20B	4.61B	4.63B	3.68B	4.34B	5.08B	5.16B	6.94B	7.72B	1.98B	8.39B	7.84B	7.26B	5.89B	6.55B	6.72B	4.09B	7.71B
Net Income Margin	2.68%	3.84%	-11.68%	10.03%	10.03%	14.40%	33.10%	28.29%	19.73%	28.24%	30.93%	27.47%	32.67%	34.22%	33.02%	27.88%	-25.20%	27.04%	22.40%	29.56%	20.68%	21.43%	27.97%	31.45%	30.74%	23.64%	25.17%	27.21%	25.71%	32.03%	33.59%	8.66%	35.35%	33.57%	28.57%	22.68%	24.89%	23.83%	12.24%	20.99%
R&D	-	-	-	-	-	-	-	-	323.60M	451.70M	528.30M	630.80M	663.30M	822.80M	845.00M	865.00M	1.12B	1.66B	2.03B	2.31B	3.37B	3.27B	3.03B	2.86B	2.89B	3.17B	3.38B	4.08B	4.30B	4.07B	3.84B	3.56B	3.74B	4.12B	4.21B	6.32B	4.43B	4.78B	5.96B	6.97B
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	19.98%	23.73%	24.03%	26.89%	25.10%	25.68%	24.50%	21.54%	20.22%	19.81%	19.22%	18.62%	23.59%	22.11%	20.20%	19.56%	19.23%	20.32%	19.58%	21.86%	21.42%	18.79%	16.70%	15.59%	15.74%	17.62%	16.55%	24.34%	16.84%	16.97%	17.84%	18.98%
Interest Expense	6.00M	15.60M	4.70M	3.90M	0	70.50M	130.10M	97.30M	208.40M	82.50M	98.80M	134.10M	222.00M	409.30M	482.10M	202.00M	12.83B	101.60M	1.06B	29.00M	2.28B	2.14B	551.00M	578.00M	604.00M	610.00M	1.05B	1.02B	1.07B	1.09B	1.26B	1.30B	1.39B	1.29B	1.26B	1.20B	1.41B	2.88B	3.15B	2.75B
Interest Expense % of Total Revenue	20.13%	35.21%	6.70%	2.05%	0.00%	10.37%	12.04%	7.18%	12.86%	4.33%	4.49%	5.72%	8.40%	12.77%	13.98%	5.03%	232.38%	1.22%	10.06%	0.23%	15.99%	14.46%	3.67%	3.95%	4.01%	3.91%	6.10%	5.47%	5.34%	5.05%	5.48%	5.71%	5.86%	5.52%	4.96%	4.61%	5.34%	10.20%	9.44%	7.50%

Balance Sheet

Currency: USD	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	96.80M	192.80M	207.10M	308.10M	514.00M	865.50M	1.37B	1.77B	1.99B	2.43B	2.77B	3.11B	3.67B	4.08B	5.40B	6.44B	24.46B	26.18B	29.22B	29.30B	33.79B	34.64B	36.44B	39.63B	43.49B	48.87B	54.30B	66.13B	69.01B	71.58B	77.63B	79.95B	66.42B	59.71B	62.95B	61.16B	65.12B	97.15B	91.84B	90.59B
Total Liabilities	12.80M	29.30M	45.20M	120.00M	116.00M	334.40M	440.60M	593.50M	719.80M	761.00M	859.30M	970.90M	1.11B	1.05B	1.09B	1.23B	6.17B	6.72B	9.52B	8.85B	14.82B	16.77B	16.06B	16.96B	19.54B	29.84B	35.24B	44.03B	43.23B	43.37B	47.75B	54.71B	53.92B	50.03B	53.54B	54.47B	61.46B	90.92B	85.96B	81.93B
Total Equity	84.00M	163.50M	161.90M	188.10M	398.00M	531.10M	933.70M	1.17B	1.27B	1.67B	1.91B	2.14B	2.56B	3.02B	4.31B	5.22B	18.29B	19.39B	19.70B	20.45B	18.96B	17.87B	20.39B	22.67B	23.94B	19.03B	19.06B	22.10B	25.78B	28.08B	29.88B	25.24B	12.50B	9.67B	9.41B	6.70B	3.66B	6.23B	5.88B	8.66B
Cash	57.60M	105.60M	20.70M	39.20M	35.70M	146.50M	92.00M	128.50M	211.30M	66.70M	169.30M	239.10M	201.10M	130.90M	226.50M	689.10M	1.85B	837.00M	1.53B	1.84B	1.28B	2.02B	1.77B	2.88B	3.29B	6.95B	3.26B	3.81B	3.73B	4.14B	3.24B	3.80B	6.95B	6.04B	6.27B	7.99B	7.63B	10.94B	11.97B	9.13B
Total Debt	7.60M	18.50M	32.20M	66.60M	14.50M	41.50M	131.90M	291.00M	283.10M	246.90M	177.20M	259.00M	328.70M	322.50M	322.70M	322.90M	3.17B	3.08B	5.11B	3.96B	9.01B	11.18B	10.18B	10.60B	13.36B	21.43B	26.53B	32.13B	30.71B	31.43B	34.60B	35.34B	33.93B	29.90B	32.99B	33.31B	38.95B	64.61B	60.10B	54.60B
Net Debt	-50.00M	-87.10M	11.50M	27.40M	-21.20M	-105.00M	39.90M	162.50M	71.80M	180.20M	7.90M	19.90M	127.60M	191.60M	96.20M	-366.20M	1.32B	2.24B	3.58B	2.12B	7.73B	9.15B	8.40B	7.72B	10.07B	14.48B	23.27B	28.32B	26.98B	27.29B	31.36B	31.54B	26.98B	23.87B	26.72B	25.32B	31.32B	53.67B	48.13B	45.48B

Cash Flow

Currency: USD	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-5.90M	18.70M	13.50M	219.70M	292.80M	433.00M	531.90M	773.20M	822.60M	902.90M	1.04B	1.08B	1.63B	1.48B	2.25B	3.57B	3.70B	4.91B	5.39B	5.40B	5.99B	6.34B	5.79B	5.12B	5.88B	6.29B	8.55B	9.08B	10.35B	11.18B	11.30B	9.15B	10.50B	9.26B	9.72B	8.47B	11.49B	9.96B
Investing Cash Flow	6.20M	-41.60M	-141.80M	-229.10M	-472.20M	-389.90M	-191.00M	-694.10M	-310.20M	-302.20M	-673.70M	-463.50M	-1.04B	-539.60M	-2.86B	-3.21B	-1.40B	-59.00M	-5.13B	-1.99B	-3.17B	-3.20B	-4.15B	-786.00M	-9.99B	-8.47B	-5.75B	-5.55B	-8.66B	-4.02B	14.34B	5.71B	-5.40B	733.00M	-6.04B	-26.20B	-1.05B	-1.94B
Financing Cash Flow	20.20M	41.50M	124.90M	100.60M	125.00M	-6.60M	-258.10M	-223.70M	-409.80M	-530.90M	-405.80M	-682.00M	-502.70M	-478.00M	1.78B	-1.37B	-1.61B	-4.54B	-815.00M	-2.67B	-3.07B	-2.02B	-1.23B	-674.00M	419.00M	2.73B	-2.88B	-3.12B	-2.60B	-6.59B	-22.49B	-15.77B	-4.87B	-8.27B	-4.04B	21.05B	-9.41B	-10.86B
Capital Expenditure	43.20M	44.10M	64.90M	117.30M	219.80M	209.90M	130.80M	162.70M	266.90M	387.80M	407.80M	304.20M	437.70M	441.80M	658.50M	1.36B	1.34B	867.00M	1.22B	1.27B	672.00M	530.00M	580.00M	567.00M	689.00M	693.00M	1.00B	649.00M	837.00M	664.00M	738.00M	618.00M	608.00M	880.00M	936.00M	1.11B	1.10B	1.86B
Free Cash Flow	-49.10M	-25.40M	-51.40M	102.40M	73.00M	223.10M	401.10M	610.50M	555.70M	515.10M	633.70M	771.10M	1.20B	1.04B	1.59B	2.21B	2.36B	4.04B	4.17B	4.13B	5.32B	5.81B	5.21B	4.55B	5.19B	5.60B	7.55B	8.43B	9.52B	10.51B	10.56B	8.53B	9.89B	8.38B	8.79B	7.36B	10.39B	8.10B
Dividends Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.98B	0	500.00M	1.12B	1.42B	1.85B	2.40B	3.00B	3.37B	3.51B	3.51B	3.75B	4.01B	4.20B	4.56B	4.83B	5.12B
FCF to OCF	832.20%	-135.83%	-380.74%	46.61%	24.93%	51.52%	75.41%	78.96%	67.55%	57.05%	60.84%	71.71%	73.22%	70.15%	70.72%	61.96%	63.86%	82.35%	77.40%	76.54%	88.78%	91.64%	89.98%	88.92%	88.29%	88.98%	88.28%	92.85%	91.92%	94.06%	93.47%	93.25%	94.21%	90.50%	90.37%	86.87%	90.46%	81.34%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	34.10%	0.00%	10.98%	21.53%	25.28%	24.51%	28.43%	31.50%	32.01%	33.22%	41.13%	37.97%	47.88%	47.76%	61.91%	46.49%	63.26%

Earnings

Report Date	Apr 17, 1996	Jul 18, 1996	Oct 15, 1996	Jan 23, 1997	Apr 17, 1997	Jul 15, 1997	Oct 22, 1997	Jan 22, 1998	Apr 22, 1998	Jul 22, 1998	Oct 27, 1998	Jan 28, 1999	Apr 20, 1999	Jul 12, 1999	Oct 20, 1999	Jan 25, 2000	Apr 25, 2000	Jul 26, 2000	Oct 26, 2000	Jan 24, 2001	Apr 26, 2001	Jul 26, 2001	Oct 25, 2001	Jan 23, 2002	Apr 25, 2002	Jul 24, 2002	Oct 23, 2002	Jan 23, 2003	Apr 22, 2003	Jul 22, 2003	Oct 21, 2003	Jan 22, 2004	Apr 22, 2004	Jul 22, 2004	Oct 20, 2004	Jan 27, 2005	Apr 21, 2005	Jul 19, 2005	Oct 19, 2005	Jan 26, 2006	Apr 18, 2006	Jul 20, 2006	Oct 23, 2006	Jan 25, 2007	Apr 23, 2007	Jul 26, 2007	Oct 24, 2007	Jan 24, 2008	Apr 24, 2008	Jul 28, 2008	Oct 22, 2008	Jan 26, 2009	Apr 23, 2009	Jul 27, 2009	Oct 21, 2009	Jan 25, 2010	Apr 21, 2010	Jul 29, 2010	Oct 25, 2010	Jan 24, 2011	Apr 20, 2011	Jul 29, 2011	Oct 24, 2011	Jan 26, 2012	Apr 24, 2012	Jul 26, 2012	Oct 23, 2012	Jan 23, 2013	Apr 23, 2013	Jul 30, 2013	Oct 22, 2013	Jan 28, 2014	Apr 22, 2014	Jul 29, 2014	Oct 27, 2014	Jan 27, 2015	Apr 21, 2015	Jul 30, 2015	Oct 28, 2015	Jan 28, 2016	Apr 28, 2016	Jul 27, 2016	Oct 27, 2016	Feb 2, 2017	Apr 26, 2017	Jul 25, 2017	Oct 25, 2017	Feb 1, 2018	Apr 24, 2018	Jul 26, 2018	Oct 30, 2018	Jan 29, 2019	Apr 30, 2019	Jul 30, 2019	Oct 29, 2019	Jan 30, 2020	Apr 30, 2020	Jul 28, 2020	Oct 28, 2020	Feb 2, 2021	Apr 27, 2021	Aug 3, 2021	Nov 2, 2021	Feb 7, 2022	Apr 27, 2022	Aug 4, 2022	Nov 3, 2022	Jan 31, 2023	Apr 27, 2023	Aug 3, 2023	Oct 31, 2023	Feb 6, 2024	May 2, 2024	Aug 6, 2024	Oct 30, 2024	Feb 4, 2025	May 1, 2025	Aug 5, 2025	Nov 4, 2025	Feb 3, 2026	Apr 30, 2026	Aug 4, 2026	Nov 3, 2026
EPS Estimate	0.13	0.15	0.15	0.16	0.16	0.18	0.17	0.17	0.17	0.18	0.20	0.21	0.22	0.23	0.24	0.25	0.25	0.27	0.27	0.25	0.27	0.28	0.29	0.31	0.27	0.28	0.32	0.35	0.39	0.46	0.51	0.48	0.55	0.60	0.62	0.61	0.67	0.72	0.82	0.75	0.88	0.94	0.98	0.94	1.08	1.06	1.03	0.97	1.04	1.03	1.08	1.05	1.14	1.17	1.27	1.11	1.24	1.30	1.27	1.10	1.29	1.29	1.30	1.22	1.45	1.55	1.47	1.44	1.84	1.74	1.79	1.68	1.94	2.07	2.12	2.05	2.11	2.42	2.37	2.28	2.61	2.74	2.80	2.79	3.01	3.11	3.10	3.03	3.25	3.56	3.45	3.27	3.48	3.58	3.53	3.42	3.75	3.77	3.75	3.35	4.04	4.01	4.22	4.04	4.12	4.33	4.45	4.09	3.85	4.49	4.68	4.59	3.89	5.00	5.11	5.08	4.26	5.28	5.01	4.73	4.77	5.60	5.74
EPS Actual	0.13	0.16	0.16	0.16	0.16	0.18	0.17	0.17	0.18	0.21	0.21	0.23	0.23	0.25	0.28	0.26	0.25	0.28	0.29	0.24	0.28	0.30	0.30	0.30	0.28	0.30	0.34	0.35	0.42	0.49	0.53	0.46	0.57	0.62	0.64	0.58	0.72	0.88	0.85	0.75	0.91	1.05	1.04	0.90	1.08	1.12	1.08	1.00	1.12	1.14	1.23	1.06	1.08	1.29	1.49	1.05	1.30	1.38	1.36	1.17	1.34	1.37	1.40	1.21	1.61	1.83	1.67	1.40	1.96	1.89	1.94	1.82	1.87	2.37	2.30	2.16	2.48	2.57	2.72	2.61	2.90	2.84	3.02	2.89	3.15	3.27	3.27	2.89	3.47	3.83	3.69	3.42	3.56	3.97	3.66	3.64	4.17	4.25	4.37	3.81	3.70	4.38	4.67	4.36	4.25	4.65	4.70	4.09	3.98	5.00	4.96	4.71	3.96	4.97	5.58	5.31	4.90	6.02	5.64	5.29	5.15	6.29	6.45
Surprise	0.00%	6.67%	6.67%	0.00%	0.00%	0.00%	0.00%	0.00%	5.88%	16.67%	5.00%	9.52%	4.55%	8.70%	16.67%	4.00%	0.00%	3.70%	7.41%	-4.00%	3.70%	7.14%	3.45%	-3.23%	3.70%	7.14%	6.25%	0.00%	7.69%	6.52%	3.92%	-4.17%	3.64%	3.33%	3.23%	-4.92%	7.46%	22.22%	3.66%	0.00%	3.41%	11.70%	6.12%	-4.26%	0.00%	5.66%	4.85%	3.09%	7.69%	10.68%	13.89%	0.95%	-5.26%	10.26%	17.32%	-5.41%	4.84%	6.15%	7.09%	6.36%	3.88%	6.20%	7.69%	-0.82%	11.03%	18.06%	13.61%	-2.78%	6.52%	8.62%	8.38%	8.33%	-3.61%	14.49%	8.49%	5.37%	17.54%	6.20%	14.77%	14.47%	11.11%	3.65%	7.86%	3.58%	4.65%	5.14%	5.48%	-4.62%	6.77%	7.58%	6.96%	4.59%	2.30%	10.89%	3.68%	6.43%	11.20%	12.73%	16.53%	13.73%	-8.42%	9.23%	10.66%	7.92%	3.16%	7.39%	5.62%	0.00%	3.38%	11.36%	5.98%	2.61%	1.80%	-0.60%	9.20%	4.53%	15.02%	14.02%	12.57%	11.84%	7.97%	12.32%	12.37%
Timing	-	-	-	-	-	Pre-market	Pre-market	Pre-market	Pre-market	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours

Key Statistics & Ratios

Market Cap251.65B

Enterprise Value292.47B

Trailing P/E26.97

Forward P/E18.83

PEG Ratio2.77

Price / Sales6.47

Price / Book17.35

EPS17.25

Book Value26.53

Revenue (TTM)38.90B

Gross Profit (TTM)28.19B

EBITDA17.63B

Profit Margin24.14%

Operating Margin35.79%

Return on Equity78.35%

Return on Assets8.91%

Shares Outstanding540.91M

Shares Float539.43M

Beta0.42

Dividend Yield2.17%

Dividend Rate10.08

Payout Ratio43.49%

Analyst Ratings

Hold

Based on 34 analystsTarget 429.74

Strong Buy
8
Buy
4
Hold
17
Sell
2
Strong Sell
3

Ownership Breakdown

Institutions: 85.19%
Insiders: 0.23%
Retail / Other: 14.58%

Top Institutional Holders

BlackRock Inc
49.36M9.13%
Vanguard Capital Management, LLC
35.25M6.52%
State Street Corp
30.56M5.65%
Capital World Investors
29.08M5.38%
Amvescap Plc.
16.32M3.02%
Geode Capital Management, LLC
15.70M2.90%
Charles Schwab Investment Management Inc
15.03M2.78%
Vanguard Portfolio Management, LLC
14.85M2.75%
Morgan Stanley - Brokerage Accounts
13.65M2.52%
Wells Fargo & Co
7.24M1.34%
PRIMECAP Management Company
6.76M1.25%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
17.16M3.17%
Vanguard 500 Index Investor
14.20M2.63%
Invesco QQQ Trust
11.25M2.08%
Schwab US Dividend Equity ETF™
10.61M1.96%
iShares Core S&P 500 ETF
7.21M1.33%
Fidelity 500 Index
7.03M1.30%
State Street® SPDR® S&P 500® ETF
6.59M1.22%
American Funds Income Fd of Amer A
6.52M1.20%
American Funds American Balanced A
6.33M1.17%

Dividends

20263×

2.52Aug 21, 20262.52May 15, 20262.52Feb 13, 2026

20254×

2.38Nov 21, 20252.38Aug 22, 20252.38May 16, 20252.38Feb 14, 2025

20244×

2.25Nov 18, 20242.25Aug 16, 20242.25May 16, 20242.25Feb 15, 2024

20234×

2.13Nov 16, 20232.13Aug 17, 20232.13May 17, 20232.13Feb 14, 2023

20224×

1.94Nov 16, 20221.94Aug 17, 20221.94May 16, 20221.94Feb 14, 2022

20214×

1.76Nov 15, 20211.76Aug 16, 20211.76May 14, 20211.76Feb 12, 2021

20201×

1.60Nov 13, 2020

Stock Splits

Nov 22, 19992:1
Mar 1, 19992:1
Aug 16, 19952:1
Sep 11, 19913:1
Aug 13, 19902:1